Edition:
India

Caplin Point Laboratories Ltd (CAPL.NS)

CAPL.NS on National Stock Exchange of India

444.95INR
9:25am IST
Change (% chg)

Rs5.80 (+1.32%)
Prev Close
Rs439.15
Open
Rs434.30
Day's High
Rs451.00
Day's Low
Rs434.30
Volume
4,052
Avg. Vol
60,207
52-wk High
Rs784.80
52-wk Low
Rs336.05

Chart for

About

Caplin Point Laboratories Limited is a pharmaceutical company. The Company's product segments include Antibiotics, Non-steroidal anti-inflammatory drugs (NSAIDS), Ophthalmics, Pain Management and Anti-ulcers. The Company offers a range of products, including Tablets, Liquid Orals, Capsule, Softgel Capsules, Suppositories and... (more)

Overall

Beta: 1.63
Market Cap(Mil.): Rs53,659.49
Shares Outstanding(Mil.): 75.58
Dividend: 1.50
Yield (%): 0.21

Financials

  CAPL.NS Industry Sector
P/E (TTM): 46.31 30.95 32.75
EPS (TTM): 15.33 -- --
ROI: -- 14.84 14.38
ROE: -- 16.34 16.07

BRIEF-Caplin Point Laboratories Considers Acquisition Opportunities

* CONSIDERED ACQUISITION OPPORTUNITIES Source text for Eikon: Further company coverage:

12 Mar 2018

BRIEF-India's Caplin Point Labs Dec-Qtr Consol Profit Rises

* DEC QUARTER CONSOL NET PROFIT 375.2 MILLION RUPEES VERSUS PROFIT 237.6 MILLION RUPEES YEAR AGO

07 Feb 2018

Earnings vs. Estimates